Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
800 studies found for:    Open Studies | "Bacterial Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bacterial Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation
2 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
3 Not yet recruiting Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Condition: Bacterial Infection
4 Recruiting Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
5 Recruiting Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection
Conditions: Febrile Shivering;   Severe Bacterial Infection
Intervention: Other: Ancillary tests
6 Recruiting Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Condition: Bacterial Infection
7 Unknown  The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
Conditions: Bacterial Infections;   Viral Infection
8 Recruiting Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Carbavance
9 Recruiting Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Condition: Bacterial Infections
Interventions: Drug: Imipenem+Cilastatin/Relebactam;   Drug: Colistimethate sodium (CMS);   Drug: Imipenem+Cilastatin;   Drug: Placebo to CMS
10 Recruiting A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Condition: Gram-Positive Bacterial Infections
Interventions: Drug: Tedizolid Phosphate (IV);   Drug: Tedizolid Phosphate (oral suspension)
11 Recruiting Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Condition: Bacterial Infection
Intervention: Drug: solithromycin
12 Recruiting Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants
Condition: Bacterial Infection
Intervention: Procedure: Analysis of the heart rate and respiratory characteristics / Telemonitoring system prototype developed by INSERM U-642
13 Recruiting Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
Condition: Gram-Negative Bacterial Infections
Interventions: Drug: Colistin;   Drug: Meropenem
14 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
15 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
16 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
17 Unknown  New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn
Condition: Nosocomial Infection
18 Recruiting Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department
Conditions: Systemic Inflammatory Response Syndrome;   Fever
Intervention: Biological: Procalcitonin (PCT) as a diagnostic marker of bacterial infection
19 Recruiting Staph Household Intervention for Eradication (SHINE)
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Staphylococcus Aureus;   MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Chlorhexidine;   Drug: Mupirocin;   Behavioral: Household cleaning
20 Recruiting The INFECIR-2 Albumin Prevention Study
Conditions: Advanced Chronic Liver Disease;   Urinary Infection;   Pneumonia;   Cholangitis;   Other Bacterial Diseases
Intervention: Drug: Albumin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years